In 2022, China's foreign trade of traditional Chinese medicine products maintained a relatively stable growth trend, with a total foreign trade volume of 8.57 billion US dollars, a year-on-year increase of 10.7%. Among them, the export value was 5.69 billion US dollars, a year-on-year increase o
New forces in international trade! Academician huangluqi, deputy director of the State Administration of traditional Chinese medicine, said at the forum that China has established overseas centers of traditional Chinese medicine in Morocco, Zimbabwe, Mauritius and other countries to serve the health
New forces in international trade! On June 25, the 7th summer summit of the World Conference on traditional Chinese medicine was held in Guiyang, Guizhou Province, with the theme of "inheritance, innovation, integration and development - promoting the high quality of traditional Chinese medicin
Building the Chongqing Pharmaceutical Group Gansu Logistics Center in Lanzhou New Area is conducive to the distribution of tertiary medical institutions in various cities, prefectures, and counties in Gansu. It can also undertake the landing of imported drugs from countries along the Belt and Road t
According to reports, the pharmaceutical market in Ukraine has a scale of 2 billion US dollars, with over 80% of its products relying on imports. At present, 220 pharmaceutical companies in Ukraine have registered and produced 4000 types of pharmaceutical products, including more than 30 original pl
With the continuous improvement of residents' consumption level, the scale of China's cosmetics market has been increasing year by year. According to the retail data of consumer goods released by the National Bureau of Statistics, from 2014 to 2021, the retail sales of cosmetics steadily inc
According to Huacheng Import and Export Data Observation, more than 30 pharmaceutical companies from around the world have announced layoff plans within six months since September 2021. Two thirds of the layoffs at pharmaceutical companies occurred in the latest quarter, with an average of 7.6 compa
Recently, China Pharmaceutical Health Industry Co., Ltd. (hereinafter referred to as "China Pharmaceutical"), a subsidiary of General technology Group, held a performance presentation meeting for 2022 and the first quarter of 2023. In 2022, China Pharmaceutical continued to expand its main
Currently, facing numerous challenges such as intensified international competition and sluggish market demand, foreign trade enterprises need to seize opportunities and grow rapidly in the changing global industrial and supply chains, without the acquisition and support of business information. In
On May 5th, the signing ceremony of the Strategic Cooperation Framework Agreement (hereinafter referred to as the Framework Agreement) between the Management Committee of Guangzhou Nansha Economic and Technological Development Zone and China Resources Guangdong Pharmaceutical Co., Ltd. was held in N
